Correction: cutaneous melanoma primary site is linked to nevus density
Authors
Martin-Gorgojo, ALlinares, M
Viros, Amaya
Requena, C
Garcia-Casado, Z
Traves, V
Kumar, R
Nagore, E
Affiliation
Escuela de Doctorado, Universidad Catolica de Valencia 'San Vicente Martir', Valencia, SpainIssue Date
2018
Metadata
Show full item recordAbstract
This corrects the article DOI: 10.18632/oncotarget.22016.Erratum for Cutaneous melanoma primary site is linked to nevus density. [Oncotarget. 2017]Citation
Martin-Gorgojo A, Llinares M, Viros A, Requena C, Garcia-Casado Z, Traves V, et al. Correction: cutaneous melanoma primary site is linked to nevus density. Oncotarget. 2018 Dec 4;9(95):36816.Journal
OncotargetDOI
10.18632/oncotarget.26445PubMed ID
30613369Additional Links
https://dx.doi.org/10.18632/oncotarget.26445Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.18632/oncotarget.26445
Scopus Count
Collections
Related articles
- Correction: BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.
- Authors: Romano E, Rufo N, Korf H, Mathieu C, Garg AD, Agostinis P
- Issue date: 2018 Dec 11
- Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
- Authors: Alon M, Arafeh R, Lee JS, Madan S, Kalaora S, Nagler A, Abgarian T, Greenberg P, Ruppin E, Samuels Y
- Issue date: 2019 Feb 12
- Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.
- Authors: Bjoern J, Lyngaa R, Andersen R, Hölmich LR, Hadrup SR, Donia M, Svane IM
- Issue date: 2018 Nov 9
- Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
- Authors: Hanson K, Robinson SD, Al-Yousuf K, Hendry AE, Sexton DW, Sherwood V, Wheeler GN
- Issue date: 2018 Nov 27
- Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
- Authors: Marciel MP, Khadka VS, Deng Y, Kilicaslan P, Pham A, Bertino P, Lee K, Chen S, Glibetic N, Hoffmann FW, Matter ML, Hoffmann PR
- Issue date: 2018 Jul 20